Neo Ivy Capital Management - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 279 filers reported holding CORCEPT THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 1.18 and the average weighting 0.2%.

Quarter-by-quarter ownership
Neo Ivy Capital Management ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$66
-35.3%
2,424
-47.3%
0.03%
-46.3%
Q2 2023$102
-77.5%
4,602
-79.4%
0.05%
-82.4%
Q4 2022$453
-77.4%
22,314
+37720.3%
0.31%
+6040.0%
Q3 2022$2,000
-98.2%
59
-98.8%
0.01%
-95.0%
Q1 2022$112,000
+229.4%
4,980
+225.7%
0.10%
+197.1%
Q2 2021$34,000
-89.3%
1,529
-88.6%
0.03%
-90.3%
Q1 2021$319,000
+3887.5%
13,419
+2531.2%
0.35%
+4275.0%
Q3 2020$8,0005100.01%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 8,372,001$98,287,0004.68%
TANAKA CAPITAL MANAGEMENT INC 79,574$934,0002.82%
Consonance Capital Management LP 3,747,453$43,995,0002.78%
S&T BANK/PA 613,740$7,205,0001.62%
AJ WEALTH STRATEGIES, LLC 595,834$6,995,0001.16%
Capital Impact Advisors, LLC 193,694$2,522,0001.12%
TEALWOOD ASSET MANAGEMENT INC 154,615$1,815,0000.77%
AMI ASSET MANAGEMENT CORP 722,932$8,487,0000.63%
Birchview Capital, LP 50,000$587,0000.37%
FEDERATED HERMES, INC. 11,176,281$131,210,0000.32%
View complete list of CORCEPT THERAPEUTICS INC shareholders